Revolution Medicines, Inc. (RVMD) Ownership

$43.84

south_east
-$0 (0%)
Day's range
$43.84
Day's range
$44.12

Revolution Medicines, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VANGUARD GROUP INC 02/11/2025 17.10 M $747.80 M   14.65% 10.25%
BLACKROCK FUNDING, INC. /DE 02/07/2025 14.72 M $643.83 M   6.15% 8.82%
FARALLON CAPITAL MANAGEMENT LLC 02/14/2025 13.25 M $579.50 M   17.06% 7.94%
WELLINGTON MANAGEMENT GROUP LLP 02/12/2025 10.82 M $473.34 M   -5.08% 6.49%
JANUS HENDERSON GROUP PLC 02/14/2025 9.48 M $414.78 M   54.53% 5.68%
BAKER BROS. ADVISORS LP 02/14/2025 7.94 M $347.16 M   4.86% 4.76%
NEXTECH INVEST LTD. 02/14/2025 7.60 M $332.47 M   20.71% 4.56%
FMR LLC 02/13/2025 6.74 M $294.90 M   14.74% 4.04%
PARADIGM BIOCAPITAL ADVISORS LP 02/14/2025 6.55 M $286.63 M   23.32% 3.93%
PRICE T ROWE ASSOCIATES INC /MD/ 02/14/2025 5.87 M $256.58 M   10.40% 3.52%
BELLEVUE GROUP AG 02/14/2025 4.39 M $191.88 M   -9.95% 2.63%
02/14/2025 4.28 M $187.18 M   100.00% 2.56%
BVF INC/IL 02/14/2025 4.18 M $182.88 M   20.20% 2.51%
ALPHABET INC. 02/07/2025 4.13 M $180.79 M   -2.89% 2.48%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 4.09 M $180.17 M   12.66% 2.45%
WOODLINE PARTNERS LP 02/14/2025 3.89 M $169.96 M   13.16% 2.33%
JPMORGAN CHASE & CO 02/12/2025 3.83 M $167.50 M   -7.46% 2.30%
CASDIN CAPITAL, LLC 02/14/2025 3.70 M $161.81 M   -10.09% 2.22%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 02/14/2025 3.26 M $142.52 M   11.87% 1.95%
HOLOCENE ADVISORS, LP 02/14/2025 3.00 M $131.08 M   39.41% 1.80%
AH CAPITAL MANAGEMENT, L.L.C. 02/12/2025 2.75 M $120.22 M   0.00% 1.65%
GOLDMAN SACHS GROUP INC 02/11/2025 2.63 M $115.04 M   11.70% 1.58%
LUNATE HOLDING RSC LTD 02/14/2025 2.20 M $96.06 M   100.00% 1.32%
LORD, ABBETT & CO. LLC 02/14/2025 1.98 M $86.55 M   8.01% 1.19%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 1.93 M $84.47 M   9.53% 1.16%
NORGES BANK 02/12/2025 1.74 M $76.20 M   100.00% 1.04%
HOOD RIVER CAPITAL MANAGEMENT LLC 02/14/2025 1.68 M $73.41 M   25.93% 1.01%
AMERIPRISE FINANCIAL INC 02/14/2025 1.63 M $71.16 M   9.52% 0.98%
MARSHALL WACE, LLP 02/13/2025 1.50 M $65.82 M   41.30% 0.90%
LOGOS GLOBAL MANAGEMENT LP 02/14/2025 1.45 M $63.42 M   20.83% 0.87%
BALYASNY ASSET MANAGEMENT L.P. 02/14/2025 1.30 M $56.99 M   -21.13% 0.78%
ROCK SPRINGS CAPITAL MANAGEMENT LP 02/14/2025 1.21 M $53.07 M   20.13% 0.73%
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 02/18/2025 997,455 $43.63 M   0.00% 0.60%
POLAR CAPITAL HOLDINGS PLC 02/14/2025 750,665 $32.83 M   100.00% 0.45%
PICTET ASSET MANAGEMENT HOLDING SA 02/12/2025 712,596 $31.17 M   4,399.56% 0.43%
FINEPOINT CAPITAL LP 02/13/2025 710,260 $31.07 M   -2.96% 0.43%
CANDRIAM S.C.A. 02/07/2025 656,740 $28.73 M   16.49% 0.39%
ADAGE CAPITAL PARTNERS GP, L.L.C. 02/14/2025 650,000 $28.43 M   124.14% 0.39%
AMERICAN CENTURY COMPANIES INC 02/11/2025 641,646 $28.07 M   11.13% 0.38%
DAFNA CAPITAL MANAGEMENT LLC 02/14/2025 631,176 $27.61 M   21.85% 0.38%
SIREN, L.L.C. 02/14/2025 571,548 $25.00 M   -24.16% 0.34%
BANK OF NEW YORK MELLON CORP 02/04/2025 569,015 $24.89 M   6.90% 0.34%
INTEGRAL HEALTH ASSET MANAGEMENT, LLC 02/14/2025 550,000 $24.06 M   57.14% 0.33%
MIC CAPITAL MANAGEMENT UK LLP 02/14/2025 508,569 $22.24 M   0.00% 0.30%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 473,728 $20.72 M   3.13% 0.28%
AVIDITY PARTNERS MANAGEMENT LP 02/14/2025 446,200 $19.52 M   -43.52% 0.27%
JANE STREET GROUP, LLC 02/14/2025 433,400 $18.96 M   68.70% 0.26%
VICTORY CAPITAL MANAGEMENT INC 02/06/2025 430,462 $18.83 M   -1.66% 0.26%
BARCLAYS PLC 02/13/2025 408,614 $17.87 M   38.67% 0.24%
FIRST TURN MANAGEMENT, LLC 02/14/2025 403,915 $17.67 M   100.00% 0.24%

Revolution Medicines, Inc. institutional Ownership - FAQ's

During the previous two years, 314 institutional investors and hedge funds held shares of Revolution Medicines, Inc.. The most heavily invested institutionals were:

VANGUARD GROUP INC: 17.1 M

BlackRock Funding, Inc. /DE: 14.72 M

FARALLON CAPITAL MANAGEMENT LLC: 13.25 M

WELLINGTON MANAGEMENT GROUP LLP: 10.82 M

JANUS HENDERSON GROUP PLC: 9.48 M

BAKER BROS. ADVISORS LP: 7.94 M

115.71% of Revolution Medicines, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 210.45 M shares in the last 24 months. This purchase volume represents approximately $9.23 B in transactions.